New and updated preclinical and clinical data presented by biopharma firms at the American Association for Cancer Research’s Virtual Annual Meeting, including: Alligator, Alpine Immune, Aptose, Astrazeneca, Compugen, Iteos, Macrogenics, Merck, Rgenix, Ribon, Sutro, Theratechnologies, Vaccinex, Verastem.